ARTICLES BY THIS AUTHOR
- 12/3/2019
Armas introduces generic Tarceva
Erlotinib has a market value of approximately $150 million annually, according to sales data. - 12/3/2019
Amneal launches 3 generics
Amneal has received the Food and Drug Administration’s clearance for three generics that it is introducing immediately, including the first generic of Carafate (sucralfate oral suspension). - 12/2/2019
Breckenridge gets FDA clearance for generic Exelon Patch
The Exelon Patch and its generics had a market value of $161 million for the 12 months ended Sept. 30, 2019. - 12/2/2019
Cumberland gets FDA nod for RediTrex
Cumberland's RediTrex injection is a treatment for adult and pediatric patients with rheumatoid arthritis, as well as adults with psoriasis. - 12/2/2019
CVS Health encourages families to get flu shots
Flu shots are available seven days a week at CVS Pharmacy and MinuteClinic locations nationwide. - 12/2/2019
Mylan, Biocon launch Herceptin biosimilar Ogivri
Mylan's Ogivri is available in 420 mg multidose vials and 150 mg single-dose vials. - 11/25/2019
Shionogi & Co. gets FDA green light for Fetroja
The FDA has approved a new antibacterial drug to treat complicated UTIs. - 11/25/2019
FDA approves Zai Lab partner, GSK’s expanded indication for Zejula
Zejula is now the only, once-daily PARP inhibitor approved as monotherapy treatment for recurrent ovarian cancer beyond those with a BRCA mutation in both the recurrent maintenance and late-line treatment settings. - 11/22/2019
SK Life Science gets FDA OK for Xcopri
The FDA has approved Xcopri, a new treatment for adults with partial-onset seizures. - 11/22/2019
Dr. Reddy's debuts generic Hectorol
Hectorol injection single-dose vials and multidose vials brand and generics had a market value of approximately $138 million for the most recent 12 months ending in September 2019, according to IQVIA.